MedTrace Logo

This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

NCT04267614 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1226

Last updated 2023-07-07

Study results available
· View outcomes & findings →

Summary

This study is to investigate the effect of etanercept in early versus delayed referral for management of rheumatoid arthritis patients assessing real-world patient data entered in the Iraq National Center of Rheumatology database between May 2012 and May 2017.

Conditions

  • Arthritis Rheumatoid

Interventions

DRUG

Etanercept

Patients who received etanercept for RA

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267614 on ClinicalTrials.gov